DexCom DXCM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $930.4M+11.3% | $836.3M+16.0% | $720.7M+26.1% | $571.5M+6.8% | $535.2M-7.1% | ||
| $258.9M+2.8% | $251.8M+3.0% | $244.4M+3.5% | $236.1M+4.8% | $225.2M+3.4% | ||
| $168.7M+5.7% | $159.6M-4.9% | $167.9M+1.0% | $166.2M+0.4% | $165.6M-2.8% | ||
| $188.3M+3.3% | $182.2M— | —— | —— | —— | ||
| —— | —— | —— | $396.5M+123% | $178.1M+409% | ||
| $135.1M+112% | $63.7M+383% | $13.2M+171% | -$18.5M+66.5% | -$55.3M-346% | ||
| —— | —— | —— | $409.2M+65.3% | $247.5M+6.8% | ||
| $10.1M-82.2% | $56.6M— | —— | —— | —— | ||
| -$19.7M-233% | $14.8M— | —— | —— | —— | ||
| -$6.9M+40.0% | -$11.5M+11.5% | -$13M-145% | -$5.3M+40.4% | -$8.9M-6.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.78B+23.7% | $1.44B-0.5% | $1.45B+46.6% | $987.7M+2.4% | $964.1M-2.6% | ||
| $353.1M-2.9% | $363.5M-5.9% | $386.2M-7.4% | $416.9M+7.2% | $388.9M+8.4% | ||
| $1.47B+18.1% | $1.25B-28.3% | $1.74B-7.0% | $1.87B-8.6% | $2.05B-20.6% | ||
| $1.98B-8.4% | $2.16B+0.2% | $2.16B-7.1% | $2.32B-1.2% | $2.35B-16.7% | ||
| -$1.1M-83.3% | -$600K-104% | $15.9M+23.3% | $12.9M-29.5% | $18.3M+18.1% | ||
| —— | —— | —— | —— | -$182.1M+12.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$7.2M-2.9% | -$7M-4.5% | -$6.7M-6.3% | -$6.3M-5.0% | -$6M+53.8% | ||
| -$1.72B-2.2% | -$1.69B-917% | -$165.8M+77.2% | -$727.3M0.0% | -$727M+1.1% | ||
| $17.5M-22.6% | $22.6M+197% | $7.6M-53.1% | $16.2M+1,346% | -$1.3M+82.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | $11.4M0.0% | $11.4M0.0% | $11.4M0.0% | $11.4M0.0% | ||
| —— | $94.4M-21.5% | $120.3M-17.7% | $146.2M-15.0% | $172.1M-13.1% | ||
| —— | —— | —— | —— | —— | ||
| $10.1M-82.2% | $56.6M— | —— | —— | —— | ||
| $7.5M+5.6% | $7.1M-11.3% | $8M— | —— | —— | ||
| -$19.7M-233% | $14.8M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.4M-12.3% | $7.3M-2.7% | $7.5M0.0% | $7.5M0.0% | $7.5M0.0% | ||
| -$1.1M-83.3% | -$600K-104% | $15.9M+23.3% | $12.9M-29.5% | $18.3M+18.1% | ||
| —— | —— | —— | —— | —— | ||
| $1.98B-8.4% | $2.16B+0.2% | $2.16B-7.1% | $2.32B-1.2% | $2.35B-16.7% | ||
| -$7.2M-2.9% | -$7M-4.5% | -$6.7M-6.3% | -$6.3M-5.0% | -$6M+53.8% | ||
| —— | $1.21B+33.3% | $905.63M+50.0% | $603.75M+100% | $301.88M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.43B+32.7% | $1.08B+1.4% | $1.06B+86.0% | $570.8M-0.8% | $575.2M-8.8% | ||
| $1.43B+32.7% | $1.08B+1.4% | $1.06B+86.0% | $570.8M-0.8% | $575.2M-8.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does DexCom generate?
- DexCom (DXCM) generated $1.8B in operating cash flow over the trailing twelve months.
- What is DexCom's free cash flow?
- After $353.1M of capital expenditures, DexCom's free cash flow was $1.4B over the trailing twelve months, up 148.5% year over year.
- Where does DexCom's cash flow data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
